Borage oil in the treatment of atopic dermatitis

作者: Rachel H. Foster , Gil Hardy , Raid G. Alany

DOI: 10.1016/J.NUT.2009.10.014

关键词:

摘要: Nutritional supplementation with omega-6 essential fatty acids (omega-6 EFAs) is of potential interest in the treatment atopic dermatitis. EFAs play a vital role skin structure and physiology. EFA deficiency replicates symptoms dermatitis, patients dermatitis have been reported to imbalances levels. Although direct proof lacking, it has hypothesized that impaired activity delta-6 desaturase enzyme, affecting metabolism linoleic acid gamma-linolenic (GLA). However, date, studies most commonly using evening primrose oil, produced conflicting results. Borage oil because contains two three times more GLA than oil. This review identified 12 clinical trials oral or topical borage for one preventive trial. All were controlled randomized double-blind, but many small had other methodological limitations. The results highly variable, effect be significant five studies, insignificant mixed studies. given at-risk neonates did not prevent development majority showed at least degree efficacy able exclude possibility produces benefit. Overall, data suggest nutritional unlikely major may useful some individual less severe who are seeking an alternative treatment. Which likely respond cannot yet identified. well tolerated short term no long-term tolerability available.

参考文章(55)
Craig C. Miller, Vincent A. Ziboh, Teresa Wong, Mark P. Fletcher, Dietary Supplementation with Oils Rich in (n-3) and (n-6) Fatty Acids Influences in Vivo Levels of Epidermal Lipoxygenase Products in Guinea Pigs The Journal of Nutrition. ,vol. 120, pp. 36- 44 ,(1990) , 10.1093/JN/120.1.36
Hoare, Li Wan Po, Williams, Systematic review of treatments for atopic eczema Health Technology Assessment. ,vol. 4, pp. 1- 191 ,(2000) , 10.3310/HTA4370
Jan Eritsland, Safety considerations of polyunsaturated fatty acids. The American Journal of Clinical Nutrition. ,vol. 71, ,(2000) , 10.1093/AJCN/71.1.197S
David F Horrobin, Essential fatty acid metabolism and its modification in atopic eczema The American Journal of Clinical Nutrition. ,vol. 71, ,(2000) , 10.1093/AJCN/71.1.367S
C.R. Charman, A.D. Morris, H.C. Williams, Topical corticosteroid phobia in patients with atopic eczema British Journal of Dermatology. ,vol. 142, pp. 931- 936 ,(2000) , 10.1046/J.1365-2133.2000.03473.X
R S Chapkin, V A Ziboh, C L Marcelo, J J Voorhees, Metabolism of essential fatty acids by human epidermal enzyme preparations: evidence of chain elongation. Journal of Lipid Research. ,vol. 27, pp. 945- 954 ,(1990) , 10.1016/S0022-2275(20)38771-X
M Andreassi, P Forleo, A Dilohjo, S Masci, G Arate, P Amerio, Efficacy of γ-Linolenic Acid in the Treatment of Patients with Atopic Dermatitis Journal of International Medical Research. ,vol. 25, pp. 266- 274 ,(1997) , 10.1177/030006059702500504
Michael J James, Robert A Gibson, Leslie G Cleland, Dietary polyunsaturated fatty acids and inflammatory mediator production The American Journal of Clinical Nutrition. ,vol. 71, ,(2000) , 10.1093/AJCN/71.1.343S